148 related articles for article (PubMed ID: 37277092)
1. Increasing numbers and complexity of Staphylococcus aureus bloodstream infection-14 years of prospective evaluation at a German tertiary care centre with multi-centre validation of findings.
Mathé P; Göpel S; Hornuss D; Tobys D; Käding N; Eisenbeis S; Kohlmorgen B; Trauth J; Gölz H; Walker SV; Mischnik A; Peter S; Hölzl F; Rohde AM; Behnke M; Fritzenwanker M; Häcker G; Steffens B; Vehreschild M; Kramme E; Falgenhauer J; Peyerl-Hoffmann G; Seifert H; Rupp J; Gastmeier P; Imirzalioglu C; Tacconelli E; Kern W; Rieg S;
Clin Microbiol Infect; 2023 Sep; 29(9):1197.e9-1197.e15. PubMed ID: 37277092
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
Bassetti M; Trecarichi EM; Mesini A; Spanu T; Giacobbe DR; Rossi M; Shenone E; Pascale GD; Molinari MP; Cauda R; Viscoli C; Tumbarello M
Clin Microbiol Infect; 2012 Sep; 18(9):862-9. PubMed ID: 21999245
[TBL] [Abstract][Full Text] [Related]
3. Treatment of community-onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: a hospital-based study.
Chen LY; Chen LK; Chang CW; Kuo SC; Li LF; Chan YJ; Wang FD
Arch Gerontol Geriatr; 2012; 55(1):152-6. PubMed ID: 21820190
[TBL] [Abstract][Full Text] [Related]
4. Impact of neutropenia on clinical manifestations and outcome of Staphylococcus aureus bloodstream infection: a propensity score-based overlap weight analysis in two large, prospectively evaluated cohorts.
Camp J; Filla T; Glaubitz L; Kaasch AJ; Fuchs F; Scarborough M; Kim HB; Tilley R; Liao CH; Edgeworth J; Nsutebu E; López-Cortés LE; Morata L; Llewelyn MJ; Fowler VG; Thwaites G; Seifert H; Kern WV; Rieg S; ;
Clin Microbiol Infect; 2022 Aug; 28(8):1149.e1-1149.e9. PubMed ID: 35339677
[TBL] [Abstract][Full Text] [Related]
5.
Jaganath D; Jorakate P; Makprasert S; Sangwichian O; Akarachotpong T; Thamthitiwat S; Khemla S; DeFries T; Baggett HC; Whistler T; Gregory CJ; Rhodes J
Am J Trop Med Hyg; 2018 Jul; 99(1):155-163. PubMed ID: 29761760
[No Abstract] [Full Text] [Related]
6. Staphylococcus aureus Bacteremia Among Patients Receiving Maintenance Hemodialysis: Trends in Clinical Characteristics and Outcomes.
Sinclair MR; Souli M; Ruffin F; Park LP; Dagher M; Eichenberger EM; Maskarinec SA; Thaden JT; Mohnasky M; Wyatt CM; Fowler VG
Am J Kidney Dis; 2022 Mar; 79(3):393-403.e1. PubMed ID: 34303771
[TBL] [Abstract][Full Text] [Related]
7. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia.
Forsblom E; Ruotsalainen E; Mölkänen T; Ollgren J; Lyytikäinen O; Järvinen A
J Hosp Infect; 2011 Jun; 78(2):102-7. PubMed ID: 21511366
[TBL] [Abstract][Full Text] [Related]
8. A Prospective Cohort Study of Durations of
Kang CK; Song KH; Kim SE; Kim ES; Park WB; Park KH; Chun SH; Lee S; Cho CR; Kang SJ; Oh MD; Kim YS; Lee SH; Kwak YG; Jang HC; Kim CJ; Kim YK; Bang JH; Kiem S; Kwon KT; Jung Y; Kang YM; Jung SI; Kim HB;
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636069
[TBL] [Abstract][Full Text] [Related]
9. Infection characteristics and treatment of Staphylococcus aureus bacteraemia at a tertiary children's hospital.
Munro APS; Blyth CC; Campbell AJ; Bowen AC
BMC Infect Dis; 2018 Aug; 18(1):387. PubMed ID: 30097020
[TBL] [Abstract][Full Text] [Related]
10. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
[TBL] [Abstract][Full Text] [Related]
11. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017.
Coombs GW; Daley DA; Lee YT; Pang S
Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522665
[TBL] [Abstract][Full Text] [Related]
12. Combination antimicrobial therapy in patients with Staphylococcus aureus bacteraemia-a post hoc analysis in 964 prospectively evaluated patients.
Rieg S; Joost I; Weiß V; Peyerl-Hoffmann G; Schneider C; Hellmich M; Seifert H; Kern WV; Kaasch A
Clin Microbiol Infect; 2017 Jun; 23(6):406.e1-406.e8. PubMed ID: 27615722
[TBL] [Abstract][Full Text] [Related]
13. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
[TBL] [Abstract][Full Text] [Related]
14. Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.
Chong YP; Moon SM; Bang KM; Park HJ; Park SY; Kim MN; Park KH; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
Antimicrob Agents Chemother; 2013 Mar; 57(3):1150-6. PubMed ID: 23254436
[TBL] [Abstract][Full Text] [Related]
15. Time trends in Staphylococcus aureus bacteremia, 1988-2010, in a tertiary center with high methicillin resistance rates.
Yahav D; Shaked H; Goldberg E; Yassin S; Eliakim-Raz N; Paul M; Bishara J; Leibovici L
Infection; 2017 Feb; 45(1):51-57. PubMed ID: 27411532
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and hospital readmission associated with complications of Staphylococcus aureus bacteremia in pediatrics over a 25-year period.
Le J; Dam Q; Tran T; Nguyen A; Adler-Shohet FC; Kim S; Schmidt K; Lieberman JM; Bradley JS
Epidemiol Infect; 2017 Sep; 145(12):2631-2639. PubMed ID: 28748772
[TBL] [Abstract][Full Text] [Related]
17. Australian Group on Antimicrobial Resistance Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2014.
Coombs GW; Daley DA; Thin Lee Y; Pearson JC; Robinson JO; Nimmo GR; Collignon P; Howden BP; Bell JM; Turnidge JD;
Commun Dis Intell Q Rep; 2016 Jun; 40(2):E244-54. PubMed ID: 27522136
[TBL] [Abstract][Full Text] [Related]
18. Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia.
Britt NS; Patel N; Shireman TI; El Atrouni WI; Horvat RT; Steed ME
J Antimicrob Chemother; 2017 Feb; 72(2):535-542. PubMed ID: 27999028
[TBL] [Abstract][Full Text] [Related]
19. The Utility of Risk Factors to Define Complicated Staphylococcus aureus Bacteremia in a Setting With Low Methicillin-Resistant S. aureus Prevalence.
van der Vaart TW; Prins JM; Goorhuis A; Lemkes BA; Sigaloff KCE; Spoorenberg V; Stijnis C; Bonten MJM; van der Meer JTM
Clin Infect Dis; 2024 Apr; 78(4):846-854. PubMed ID: 38157401
[TBL] [Abstract][Full Text] [Related]
20. Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
Kaasch AJ; Fätkenheuer G; Prinz-Langenohl R; Paulus U; Hellmich M; Weiß V; Jung N; Rieg S; Kern WV; Seifert H;
Trials; 2015 Oct; 16():450. PubMed ID: 26452342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
